Bio-Techne Corporation
USD50.85
+1.08 (+2.17%)
CEO
Kim Kelderman
IPO Date
1989-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$49.58
Prev. Close
$49.77
Day Low
$49.03
Day High
$50.88
52W Low
$43.20
52W High
$72.16
Market Cap
$7.96B
Volume
2.11M
| 67.2 |
| 30 Jun 2023 | FY | 67.7% | 25.1% | 14.5% | 10.8% | 0.23 | 4.84 | 45.0 |
| 30 Jun 2022 | FY | 68.4% | 24.6% | 16.0% | 11.9% | 0.19 | 3.44 | 50.0 |
| 30 Jun 2021 | FY | 68.0% | 15.1% | 8.9% | 6.2% | 0.27 | 3.35 | 124.3 |
| 30 Jun 2020 | FY | 65.4% | 31.0% | 16.6% | 11.3% | 0.31 | 4.88 | 44.0 |
| 30 Jun 2019 | FY | 66.3% | 13.5% | 8.2% | 5.1% | 0.43 | 4.05 | 82.3 |
| 30 Jun 2018 | FY | 67.2% | 19.5% | 11.6% | 7.9% | 0.32 | 5.06 | 44.2 |
| 30 Jun 2017 | FY | 66.5% | 13.7% | 8.1% | 5.0% | 0.37 | 2.55 | 56.7 |
| 30 Jun 2016 | FY | 67.5% | 20.9% | 11.9% | 9.2% | 0.15 | 4.69 | 40.1 |
| 56.6 |
| 30 Jun 2025 | Q4 | 62.7% | -5.6% | -0.9% | -0.7% | 0.23 | 3.46 | -112.7 |
| 31 Mar 2025 | Q3 | 67.9% | 7.1% | 1.1% | 0.9% | 0.21 | 3.71 | 102.1 |
| 31 Dec 2024 | Q2 | 65.3% | 11.7% | 1.7% | 1.3% | 0.19 | 3.94 | 81.8 |
| 30 Sept 2024 | Q1 | 63.2% | 11.6% | 1.6% | 1.2% | 0.19 | 4.56 | 94.3 |
| 30 Jun 2024 | Q4 | 66.9% | 13.3% | 2.0% | 1.4% | 0.20 | 3.87 | 69.6 |
| 31 Mar 2024 | Q3 | 67.6% | 16.2% | 2.4% | 1.8% | 0.20 | 4.08 | 55.6 |
| 31 Dec 2023 | Q2 | 64.8% | 10.1% | 1.4% | 1.0% | 0.28 | 4.37 | 110.6 |
| 30 Sept 2023 | Q1 | 66.9% | 18.4% | 2.6% | 1.9% | 0.28 | 4.63 | 52.8 |